423 related articles for article (PubMed ID: 35884791)
1. The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases.
Ghezzi L; Cantoni C; Rotondo E; Galimberti D
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884791
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
Zheng Y; Bonfili L; Wei T; Eleuteri AM
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
[TBL] [Abstract][Full Text] [Related]
3. Targeting the gut to treat multiple sclerosis.
Ghezzi L; Cantoni C; Pinget GV; Zhou Y; Piccio L
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34196310
[TBL] [Abstract][Full Text] [Related]
4. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
5. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in depression and gut-brain axis: A molecular crosstalk.
Begum N; Mandhare A; Tryphena KP; Srivastava S; Shaikh MF; Singh SB; Khatri DK
Front Aging Neurosci; 2022; 14():1048333. PubMed ID: 36583185
[TBL] [Abstract][Full Text] [Related]
7. Obesity and gut-microbiota-brain axis: A narrative review.
Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
[TBL] [Abstract][Full Text] [Related]
8. A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation.
Hashim HM; Makpol S
Front Cell Neurosci; 2022; 16():1007166. PubMed ID: 36406749
[TBL] [Abstract][Full Text] [Related]
9. Implications of Gut Microbiota in Neurodegenerative Diseases.
Zhang H; Chen Y; Wang Z; Xie G; Liu M; Yuan B; Chai H; Wang W; Cheng P
Front Immunol; 2022; 13():785644. PubMed ID: 35237258
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke.
Chidambaram SB; Rathipriya AG; Mahalakshmi AM; Sharma S; Hediyal TA; Ray B; Sunanda T; Rungratanawanich W; Kashyap RS; Qoronfleh MW; Essa MM; Song BJ; Monaghan TM
Cells; 2022 Apr; 11(7):. PubMed ID: 35406804
[TBL] [Abstract][Full Text] [Related]
11. Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders.
Toledo ARL; Monroy GR; Salazar FE; Lee JY; Jain S; Yadav H; Borlongan CV
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163103
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention.
Bhuiyan P; Chen Y; Karim M; Dong H; Qian Y
Brain Res Bull; 2021 Jul; 172():61-78. PubMed ID: 33892083
[TBL] [Abstract][Full Text] [Related]
13. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis.
Person H; Keefer L
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110209. PubMed ID: 33326819
[TBL] [Abstract][Full Text] [Related]
14. Microbiome-The Missing Link in the Gut-Brain Axis: Focus on Its Role in Gastrointestinal and Mental Health.
Skonieczna-Żydecka K; Marlicz W; Misera A; Koulaouzidis A; Łoniewski I
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30544486
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
[TBL] [Abstract][Full Text] [Related]
16. The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications.
Khawar MM; Ijaz S; Goyal P; Kandambige D; Sharifa M; Maslamani ANJ; Al Kutabi S; Saleh I; Albshir MM; I Kh Almadhoun MK; Soomro SN; Kumari N
Cureus; 2023 Nov; 15(11):e48655. PubMed ID: 38090441
[TBL] [Abstract][Full Text] [Related]
17. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
18. Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?
Martinelli V; Albanese M; Altieri M; Annovazzi P; Arabi S; Bucello S; Caleri F; Cerqua R; Costanzi C; Cottone S; Dalla Costa G; Direnzo V; Fantozzi R; Favaretto A; Lorefice L; Montini F; Noce A; Plewnia K; Repice AM; Sacco R; Vecchio D
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):935-946. PubMed ID: 35179760
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiome and Modulation of CNS Function.
Osadchiy V; Martin CR; Mayer EA
Compr Physiol; 2019 Dec; 10(1):57-72. PubMed ID: 31853944
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review on the pharmacological role of gut microbiome in neurodegenerative disorders: potential therapeutic targets.
Aziz N; Wal P; Patel A; Prajapati H
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38734839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
